The Biotech Growth Trust – equity proposition
Equity proposition
27 August 2024
The Biotech Growth Trust (BIOG) seeks capital appreciation through investing in the worldwide biotechnology industry. Performance is measured against its benchmark index, the NASDAQ Biotechnology Index (sterling adjusted). Below we highlight four things investors need to know about BIOG: 1. The trust focuses on capital growth via investment in the global biotechnology industry. 2. Biotech industry fundamentals are favourable. 3. BIOG’s small-cap bias is likely to benefit its returns in a declining interest rate environment. 4. The trust’s managers can draw on OrbiMed’s extensive resources. To learn more about BIOG, read our latest research here: https://www.edisongroup.com/equity/the-biotech-growth-trust/ MORE »
